Why Is Teva Stock Trading Higher On Tuesday?

benzinga.com/general/biotech/25/05/45629452/why-is-teva-stock-trading-higher-on-tuesday

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and Biolojic Design Ltd announced that Teva initiated IND-enabling studies with BD9, a dual-specific multibody targeting both TSLP (Thymic stromal lymphopoietin) and IL-13.
Teva has an exclusive license to develop BD9 for TH2-driven…

This story appeared on benzinga.com, 2025-05-27 19:44:51.
The Entire Business World on a Single Page. Free to Use →